Replies to post #4498 on Manhattan Scientifics Inc (MHTX)

[jim30jen]

The company is required to disclose all "material" events. If (worst case scenario) MDA determined that the MRX technology has no place in modern medicine and returned the machine(s), This would be considered a "material" event and would have to be disclosed.

Since the technology is "broad spectrum" as far as its potential uses, it can't be thoroughly evaluated in "one pass"!

Cancer is a multi faced disease. It takes time to evaluate the process in relation to each type of cancer cell. I'm not a medical professional but I know that there are at least three types of breast cancers and four types of thyroid cancers and many others.

As long as there has been no announcement to the contrary, good things are happening and there will be news when there is a "material" event.

[TruBud1]

Just to keep things in perspective... MRI technology began in 1946. It was primarily used for industrial applications. The first human examination wasn't done until 1977. With additional advances, Drs. Lauterbun and Mansfield won the Nobel Prize for applying the MRI for diagnostic technology... IN 2003. If this is the current arc of medical technology development... we have decades of sour griping to anticipate. Note to self: Make sideline investment in pharma working on longterm time release, mind-numbing sedatives.